Medical Device News Magazine

Camber Spine Continues to Add to its “All Angles” Product Portfolio with Latest Patent Approval

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Camber Spine, a leading innovator in spine and medical technologies has announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its Variant Retractor technology, bringing the company’s total patent portfolio to 47 patents.

The Variant Retractor is a tool designed to provide flexible spacing support for a variety of spine surgical approaches.

“As our IP portfolio continues to grow, so too does the positive impact we can make for our surgeon customers and their patients,” said Camber Spine Co-Founder and CEO, Daniel Pontecorvo.  “With this latest patent grant from the USPTO, we have now received 47 issued patents, further strengthening our value proposition of offering a broad selection of tools to surgeons that accommodate spine surgery approaches and techniques from literally every possible angle.”

“We are extremely proud of our engineering and manufacturing teams for creating such a robust collection of devices,” added Pontecorvo, “all with the highest structural integrity and quality standards, and we look forward to the remainder of 2022 and a pipeline full of additional product offerings.”

With further expansions to its lines of award-winning Spira and Enza technology platforms due later this year, along with training labs and educational programs to support ALIF, LLIF, OLIF, PLIF and TLIF spine surgery techniques, the company is focused on fulfilling its mission to support the full array of surgical approaches.

The Camber Spine collection of devices will be on display at the American Association of Neurological Surgeons (AANS) Annual Meeting at the Pennsylvania Convention Center (booth #204 on the exhibit floor.  Camber’s booth will also be hosting a series of focus sessions:

  • “Posterior Approach” April 30 at 10:00am;
  • “Advanced Biologics” April 30 at 1:00pm; and
  • “Anterior Column” May 1 at 10:00am.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”